The emergence and evolution of methicillin-resistant Staphylococcus aureus

K Hiramatsu, L Cui, M Kuroda, T Ito - Trends in microbiology, 2001 - cell.com
Significant advances have been made in recent years in our understanding of how
methicillin resistance is acquired by Staphylococcus aureus. Integration of a staphylococcal …

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

K Hiramatsu - The Lancet infectious diseases, 2001 - thelancet.com
Vancomycin has been the most reliable therapeutic agent against infections caused by
meticillin-resistant Staphylococcus aureus (MRSA). However, in 1996 the first MRSA to …

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada …

DJ Diekema, MA Pfaller, FJ Schmitz… - Clinical infectious …, 2001 - academic.oup.com
Abstract Between January 1997 and December 1999, bloodstream isolates from 15,439
patients infected with Staphylococcus aureus and 6350 patients infected with coagulase …

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

M Wootton, RA Howe, R Hillman… - Journal of …, 2001 - academic.oup.com
One hundred methicillin-resistant Staphylococcus aureus (MRSA) strains, isolated between
1983 and 1999, were tested alongside the vancomycin hetero-resistant S. aureus (hVRSA) …

Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility

BP Howden, PB Ward, PGP Charles… - Clinical Infectious …, 2004 - academic.oup.com
Although infections caused by methicillin-resistant Staphylococcus aureus with reduced
vancomycin susceptibility (SA-RVS) have been reported from a number of countries …

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.

FC Tenover, JW Biddle… - Emerging infectious …, 2001 - ncbi.nlm.nih.gov
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been
reported from Japan, the United States, Europe, and the Far East. Although isolates with …

Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

PGP Charles, PB Ward, PDR Johnson… - Clinical infectious …, 2004 - academic.oup.com
We assessed all episodes of methicillin-resistant Staphy lococcus aureus (MRSA)
bacteremia at our hospital during a 12-month period (n= 53) and compared those due to …

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

C Liu, HF Chambers - Antimicrobial agents and chemotherapy, 2003 - Am Soc Microbiol
The first report of Staphylococcus aureus with intermediate-level resistance to vancomycin
(VISA) was from Japan in 1997 (20), raising the threat of incurable staphylococcal infections …

Epidemiology and Susceptibility of 3,051Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study

AC Fluit, CLC Wielders, J Verhoef… - Journal of clinical …, 2001 - Am Soc Microbiol
ABSTRACT A total of 3,051 methicillin-susceptible Staphylococcus aureus (MSSA) isolates
and methicillin-resistant S. aureus (MRSA) isolates in Europe were compared. MRSA …

[HTML][HTML] Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus …

S Zhang, X Sun, W Chang, Y Dai, X Ma - PloS one, 2015 - journals.plos.org
Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …